Liver fibrosis assessed using non-invasive markers and genetic polymorphisms (PNPLA3 and TM6SF2) predisposing to liver fibrosis, is associated with hospitalization or death from heart failure: a prospective UK Biobank study https://www.medrxiv.org/content/10.1101/2023.08.23.23294514